PerkinElmer Expands Its OneSource(R) Laboratory Services with Acquisition of LabMetrix Technologies

Brings Industry’s Most Comprehensive Regulatory Compliance Solutions to Customers WALTHAM, Mass.–PerkinElmer, Inc. (NYSE: PKI – News), a global leader in Health Sciences and Photonics, today announced the acquisition of LabMetrix Technologies, the largest independent provider of metrology-based multi-vendor analytical instrument qualification solutions. The acquisition of LabMetrix adds technology, tools, proven processes and compliance expertise to PerkinElmer’s growing suite of OneSource® laboratory services, strengthening its support of customers in a wide range of industries including pharmaceutical, medical device, food, toy and other consumer goods. The terms of the deal were not disclosed. “This acquisition expands our support of customers in regulated markets by combining metrology-based multi-vendor qualification solutions with PerkinElmer’s existing services capabilities,” said Robert F. Friel, president and chief executive officer, PerkinElmer. “With the addition of LabMetrix’s technology-assisted compliance solution, we can provide customers with the most robust qualification environment available for a broad range of instruments and technologies in their labs, regardless of manufacturer.” Greater public attention on product safety coupled with customers’ increased need for improved scientific output continue to drive greater demand for comprehensive regulatory compliance solutions. The combination of LabMetrix’s technology solutions with PerkinElmer’s existing OneSource offerings will make it significantly easier for customers to demonstrate the accuracy of their analytical measurements while helping drive down the cost of compliance through automation, standardization and streamlined documentation. LabMetrix generated revenues of approximately $5 million in 2007. “We are excited by the opportunity to combine the strengths of PerkinElmer’s qualification capabilities with our patented solutions,” said Serge Njamfa, president and chief executive officer, LabMetrix Technologies. “For over twenty years, we have successfully qualified thousands of analytical instruments. We look forward to combining our proven technologies with PerkinElmer’s outstanding global service presence to offer customers the most comprehensive and cost-effective services available from any supplier.” Factors Affecting Future Performance This press release contains “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to estimates and projections of future earnings per share, cash flow, revenue growth and other financial results, developments relating to our customers and end-markets, and plans concerning business development opportunities. Words such as “believes,” “intends,” “anticipates,” “plans,” “expects,” “projects,” “forecasts,” “will” and similar expressions, and references to guidance, are intended to identify forward-looking statements. Such statements are based on management’s current assumptions and expectations and no assurances can be given that our assumptions or expectations will prove to be correct. A number of important risk factors could cause actual results to differ materially from the results described, implied or projected in any forward-looking statements. These factors include, without limitation: (1) our failure to introduce new products in a timely manner; (2) our ability to execute acquisitions and license technologies, or to successfully integrate acquired businesses and licensed technologies into our existing business or to make them profitable; (3) our failure to protect adequately our intellectual property; (4) the loss of any of our licenses or licensed rights; (5) our ability to compete effectively; (6) fluctuation in our quarterly operating results and our ability to adjust our operations to address unexpected changes; (7) our ability to produce an adequate quantity of products to meet our customers’ demands; (8) our failure to maintain compliance with applicable government regulations; (9) regulatory changes; (10) our failure to comply with health care industry regulations; (11) economic, political and other risks associated with foreign operations; (12) our ability to retain key personnel; (13) restrictions in our credit agreements; (14) our ability to realize the full value of our intangible assets; and (15) other factors which we describe under the caption “Risk Factors” in our most recent annual report on Form 10-K and in our most recent quarterly report on Form 10-Q and in our other filings with the Securities and Exchange Commission. We disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this press release. PerkinElmer, Inc. is a global technology leader driving growth and innovation in Health Sciences and Photonics markets to improve the quality of life. The Company reported revenues of $1.8 billion in 2007, has 9,100 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through or 1-877-PKI-NYSE.

< | >